<h3>认识您的 ETF 人工智能分析师</h3>
<ul>
<li>了解 TipRanks 的_ETF_人工智能分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong>_ETF_人工智能分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
<p>IVD Medical Holding Limited（(HK:1931)）刚刚发布了一项更新。</p>
<p>IVD Medical Holding Limited 已宣布收购 B-Soft Co., Ltd.的重大股份，此举使公司在 B-Soft 中持有约 12.64% 的投票权。这项价值 5 亿人民币的战略收购涉及购买 96,525,096 股 A 股，占 B-Soft 总发行股本的 6.23%。此外，公司通过与供应商和一家私募基金的协议，获得了额外 195,780,282 股 A 股的投票权。该交易被归类为根据上市规则第 14 章的可披露交易，需进行报告和公告，但免于股东批准。收购需依赖监管批准及其他条件，利益相关者应谨慎行事。</p>
<p>（HK:1931）股票的最新分析师评级为持有，目标价格为 7.00 港元。要查看 IVD Medical Holding Limited 股票的完整分析师预测列表，请参见 HK:1931 股票预测页面。</p>
<p><strong>关于 IVD Medical Holding Limited 的更多信息</strong></p>
<p><strong>平均交易量：</strong> 2,459,716</p>
<p><strong>技术情绪信号：</strong> 买入</p>
<p><strong>当前市值：</strong> 97.1 亿港元</p>

创业慧康

华检医疗

<p>IVD Medical Holding Limited 已经收购了 B-Soft Co., Ltd 的重要股份，持有约 12.64% 的投票权。此次收购的价值为人民币 5 亿元，涉及购买 96,525,096 股 A 股，并获得额外 195,780,282 股 A 股的投票权。该交易被归类为上市规则第 14 章下的可披露交易，需进行报告但免于股东批准。此次收购需获得监管机构的批准</p>

<h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF 人工智能分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>了解 TipRanks 的_ETF_人工智能分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong>_ETF_人工智能分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
</div><p>IVD Medical Holding Limited ( (HK:1931) ) just unveiled an update.</p>
<div class="lb-trans"><p>IVD Medical Holding Limited（(HK:1931)）刚刚发布了一项更新。</p>
</div><p>IVD Medical Holding Limited has announced its acquisition of a significant stake in B-Soft Co., Ltd, a move that positions the company to hold approximately 12.64% of the voting rights in B-Soft. This strategic acquisition, valued at RMB500 million, involves the purchase of 96,525,096 A shares, representing 6.23% of B-Soft’s total issued share capital. Additionally, the company has secured voting rights for an additional 195,780,282 A shares through agreements with the vendor and a private fund. This transaction is classified as a discloseable transaction under Chapter 14 of the Listing Rules, requiring reporting and announcement but exempt from shareholder approval. The acquisition is contingent on regulatory approvals and other conditions, and stakeholders are advised to exercise caution.</p>
<div class="lb-trans"><p>IVD Medical Holding Limited 已宣布收购 B-Soft Co., Ltd.的重大股份，此举使公司在 B-Soft 中持有约 12.64% 的投票权。这项价值 5 亿人民币的战略收购涉及购买 96,525,096 股 A 股，占 B-Soft 总发行股本的 6.23%。此外，公司通过与供应商和一家私募基金的协议，获得了额外 195,780,282 股 A 股的投票权。该交易被归类为根据上市规则第 14 章的可披露交易，需进行报告和公告，但免于股东批准。收购需依赖监管批准及其他条件，利益相关者应谨慎行事。</p>
</div><p>The most recent analyst rating on (HK:1931) stock is a Hold with a HK$7.00 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.</p>
<div class="lb-trans"><p>（HK:1931）股票的最新分析师评级为持有，目标价格为 7.00 港元。要查看 IVD Medical Holding Limited 股票的完整分析师预测列表，请参见 HK:1931 股票预测页面。</p>
</div><p><strong>More about IVD Medical Holding Limited</strong></p>
<div class="lb-trans"><p><strong>关于 IVD Medical Holding Limited 的更多信息</strong></p>
</div><p><strong>Average Trading Volume:</strong> 2,459,716</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 2,459,716</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 买入</p>
</div><p><strong>Current Market Cap:</strong> HK$9.71B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> 97.1 亿港元</p>
</div>

华检医疗收购了创业慧康有限公司的重大股份